CERIMON PHARMACEUTICALS
DEAD

Serial Number

77290877

Owner

Cerimon Pharmaceuticals, Inc.

Attorney

ANDREW M. ABRAMS

First Use Date

Sep 25, 2007

Filing Date

Sep 27, 2007

Add to watchlist:

No watchlists yet
View on USPTO

CERIMON PHARMACEUTICALS Trademark

Serial Number: 77290877 • Registration: 3529970

CERIMON PHARMACEUTICALS is a trademark filed by Cerimon Pharmaceuticals, Inc. on September 27, 2007. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Cerimon Pharmaceuticals, Inc. (4 trademarks)

111 Huntington Avenue
Boston, MA 02199

Entity Type: 03

Trademark Details

Filing Date

September 27, 2007

Registration Date

November 11, 2008

First Use Anywhere

September 25, 2007

First Use in Commerce

September 25, 2007

Published for Opposition

August 26, 2008

Cancellation Date

June 12, 2015

Goods & Services

Pharmaceutical and biopharmaceutical preparations and substances for the treatment of gastro-intestinal, auto-immune, inflammatory and pain diseases; pharmaceutical and biopharmaceutical preparations and substances for the treatment of gastro-intestinal, auto-immune, inflammatory and pain diseases, namely, ulcerative colitis, acute and chronic pain due to osteoarthritis, sprains, tendonitis or bursitis

Filing History

CANCELLED SEC. 8 (6-YR)
Jun 12, 2015 C8..
REGISTERED-PRINCIPAL REGISTER
Nov 11, 2008 R.PR
PUBLISHED FOR OPPOSITION
Aug 26, 2008 PUBO
NOTICE OF PUBLICATION
Aug 6, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 21, 2008 PREV
ASSIGNED TO LIE
Jul 21, 2008 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 21, 2008 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 28, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 27, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 27, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 31, 2007 GNRN
NON-FINAL ACTION E-MAILED
Dec 31, 2007 GNRT
NON-FINAL ACTION WRITTEN
Dec 31, 2007 CNRT
ASSIGNED TO EXAMINER
Dec 31, 2007 DOCK
NEW APPLICATION ENTERED
Oct 2, 2007 NWAP